Il-18: A Potential Inflammation Biomarker In Wiskott-Aldrich Syndrome

EUROPEAN JOURNAL OF IMMUNOLOGY(2021)

引用 1|浏览5
暂无评分
摘要
Analysis of serum cytokine levels in Wiskott-Aldrich syndrome patients pre- and post- treatment reveals IL-18 as a stable and reliable marker of inflammation. Definitive stem cell treatment with good myeloid correction correlates with resolution of inflammation and reduction of circulating IL-18, highlighting the importance of actin cytoskeletal regulation of myeloid cells in control of inflammation.
更多
查看译文
关键词
Autoinflammation,IL-18,IL-1β,Inflammasome,Wiskott Aldrich syndrome
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要